¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse brain atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® brain stem ÇÑ±Û ³úÁÙ±â
¼³¸í   
  ³úÁÙ±âÀ̶õ ´ë³ú¿Í Ã´¼ö¸¦ À̾îÁִ ´Ù¸® ¿ªÇÒÀ» Çϴ ³úÀÇ ºÎºÐÀ¸·Î À̰÷¿¡´Â Áß°£³ú, ´Ù¸®³ú, ¼û³úÀÇ 3°³ÀÇ ºÎºÐÀÌ Æ÷ÇԵȴÙ. À̰÷Àº ´ë³ú¿¡¼­ ³ª°¡´Â ¿îµ¿½Å°æ°ú ´ë³ú·Î µé¾î¿À´Â °¨°¢½Å°æÀÇ Áß¿äÇÑ Åë·Î°¡ Àִ °÷À̸ç, µ¿½Ã¿¡ ´ëºÎºÐÀÇ ³ú½Å°æ(ô¼ö¸¦ °ÅÄ¡Áö ¾Ê°í ³ª°¡´Â ½Å°æ, Áï ³ú¿¡¼­ Á÷Á¢ ³ª¿À°í µé¾î¿À´Â ½Å°æÀ» À̸£´Â ¸»)ÀÇ Áß¿äÇÑ ¿äÁöÀÌ´Ù.
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse reflection
    ±¤¹üÀ§¹Ý»ç
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • diffuse sclerosis
    ±¤¹üÀ§°æÈ­Áõ
  • diffuse systemic sclerosis
    ±¤¹üÀ§Àü½Å°æÈ­Áõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • blood-brain barrier
    Ç÷¾×³úÀ庮
  • brain
    ³ú
  • brain abscess
    ³ú°í¸§Áý, ³ú³ó¾ç
  • brain CT
    ³úÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(¼ú)
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain infarct
    ³ú°æ»ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minor brain damage
    °æµµ³ú¼Õ»ó
  • elective brain irradiation
    ¿¹¹æ³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • organic brain syndrome
    ±âÁú³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • diffuse aneurysm
    ±¤¹üÀ§µ¿¸ÆÀÚ·ç, ±¤¹üÀ§µ¿¸Æ·ù
  • diffuse arteriosclerosis
    ±¤¹üÀ§µ¿¸Æ°æÈ­Áõ
  • diffuse atelectasis
    ±¤¹üÀ§¹«±âÆó
  • diffuse intravascular coagulation
    ¹Ì¸¸Ç÷°ü³»ÀÀ°í
  • diffuse
    ±¤¹üÀ§-, È®»ê-, ¹Ì¸¸-
  • degenerative diffuse cerebral sclerosis
    ÅðÇ౤¹üÀ§³ú°æÈ­(Áõ)
  • diffuse erythema
    ±¤¹üÀ§È«¹Ý
  • diffuse goiter
    ¹Ì¸¸°©»ó»ùÁ¾, ±¤¹üÀ§¹æÆÐ»ùÁ¾
  • diffuse inflammation
    ¹Ì¸¸¿°Áõ
  • diffuse placenta
    ÆÛÁøÅ¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prosencephalon =fore brain
    Àü³ú.
  • prosencephalon =fore brain
    Àü³ú.
  • radiation brain necrosis
    ¹æ»ç¼±³ú±«»ç
  • Sudecks atrophy
    ¼öµ¦ À§Ãà
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)ÀÇ .
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)
  • alveolar atrophy<³ª> atrophia alveolaris
    Ä¡Á¶À§Ãà(öÍðËê×õê).
  • gastric atrophy
    À§¼±À§Ãà(êÖàÍê×õê).
  • gastric mucosa atrophy
    À§Á¡¸·À§Ãà.
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • gingival atrophy
    Ä¡ÀºÀ§Ãà(öÍó»ê×õê).
  • glaucomatous optic nerve atrophy
    ³ì³»Àå½Ã½Å°æÀ§Ãà.
  • granular atrophy of kidney
    ½ÅÀå°ú¸³¼ºÀ§Ãà.
  • gray optic atrophy
    ȸ»ö½Ã½Å°æÀ§Ãà
  • halisteretic atrophy
    Żȸ¼º À§Ãà(÷­üéàõê×õê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse collagen disease
    ¹Ì¸¸¼º ±³¿øº´.
  • diffuse cutaneous mastocytosis
  • diffuse elastoma of Dubreuilh
    µàºê·çÀÌ ±¤¹üÀ§ ź·Â ¼¶À¯Á¾
  • diffuse esophageal spasm
    ¹Ì¸¸¼º½Äµµ°æ·Ã, ¹Ì¸¸¼º½Äµµ¿¬Ãà.
  • diffuse exfoliative erythroderma
    ¹Ì¸¸¼º<¹ü¹ß¼º> ¹Ú¸®¼º È«ÇÇÁõ.
  • diffuse external otitis
    ¹ü¹ß(¼º) ¿ÜÀ̵µ¿°
  • diffuse familial comedo
    ±¤¹üÀ§ °¡Á·¼º ¸éÆ÷
  • diffuse fascitis
  • diffuse goiter
    ¹Ì¸¸¼º °©»ó¼±Á¾(¡­°©»ó¼±Á¾).
  • diffuse goiter
    ¹Ì¸¸¼º °©»ó¼±Á¾(¡­Ë£ßÒàÍðþ).
  • diffuse granulomatosis
    ¹Ì¸¸¼º À°¾ÆÁ¾(Áõ).
  • diffuse inflammation
    ¹Ì¸¸¼º ¿°Áõ.
  • diffuse interstitial keratitis
    ±¤¹üÀ§°£Áú°¢¸·¿°, ¹Ì¸¸¼º°£Áú°¢¸·¿°
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º °£Áú¼º Æó·Å.
  • diffuse interstitial pulmonary disease
    ¹Ì¸¸¼º °£Áú¼º ÆóÁúȯ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà
  • senile atrophy
    ³ë³â(³ëÀÎ)¼ºÀ§Ãà
  • thenar atrophy
    ¹«Áö±¸À§Ãà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
atr atrophy
AYA acute yellow atrophy
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
CSMA chronic spinal muscular atrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GA Gyrate atrophy
HCSMA Hereditary Canine Spinal Muscular Atrophy
HA Hippocampal atrophy
MSA Multiple System Atrophy
OPCA Olivo-Ponto-Cerebellar Atrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffuse thickening
    ¹Ì¸¸¼º ºñÈÄ
  • diffuse waxy spleen
    ¹Ì¸¸¼º ³³ ºñ
    ºñÀåÀÇ ¾Æ¹Ð·ÎÀÌµå º¯¼ºÀ¸·Î¼­ ƯÈ÷ Á¤¸Æµ¿ÀÇ ¿ÜÃþ°ú ¸Á»ó Á¶Á÷ÀÌ Ä§½ÀµÈ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • blood-brain barrier
    Ç÷³ú À庮
    ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ Á¸ÀçÇϰí À̰ÍÀ» Ç÷³ú À庮À̶ó ÇÑ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ´Ù¸¥ ¸ð¼¼Ç÷°ü¿¡ ºñÇØ ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
  • brain abscess
    ³ú ³ó¾ç
    ³ú ³ó¾çÀº ³ú ½ÇÁú³»¿¡ ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, ¿øÃæ·ùµéÀÇ °¨¿°¿¡ ÀÇÇÏ¿© ¹ß»ýµÇ´Â ±¹ÇÑµÈ È­³ó¼º ÁúȯÀÌ´Ù. 1. ¿øÀÎ : ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, È¿¸ð±Õ, ±â»ýÃæ µîÀÌ ³ú ³ó¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç, °ú°Å¿¡´Â ¿¬¼â»ó ±¸±Õ, Æ÷µµ»ó ±¸±Õ, Àå³»±Õ, Æó·Å ±¸±Õ µîÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ̾úÀ¸³ª ±Ù·¡¿¡ ¿Í¼­ Ç×»ýÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ¸é¿ª°áÇÌÁõ ȯÀÚÀÇ Áõ°¡ µîÀ¸·Î ¼Ò °£±Õ, Çø±â¼º ¿¬¼â»ó ±¸±ÕÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ¸·Î µÇ¾úÀ¸¸ç, Nocardia±Õ, Áø±Õ, ±â»ýÃæÀÇ ºóµµµµ ³ô¾ÆÁö°í ÀÖ´Ù. °¨¿° °æ·Î¸¦ º¸¸é ÁßÀÌ¿°À̳ª ºÎºñµ¿¿°¿¡¼­ Á÷Á¢ ¶Ç´Â ³ú ÇÇÁú, ³ú°æ¸·ÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© °¨¿°µÇ°Å³ª µÎºÎÀÇ °üÅë»óÀ̳ª µÎºÎ ¼ö¼úÈÄÀÇ ÇÕº´ÁõÀ¸·Î Ç÷·ù¸¦ ÅëÇÑ ÆÐÇ÷¼º »öÀüÀ» ÅëÇÏ¿© ¶Ç´Â ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°À̳ª ¼±Ãµ¼º ½ÉÀ庴 ±×¸®°í ¸é¿ª±â´ÉÀÌ ÀúÇÏµÈ °æ¿ì¿¡ ÁÖ·Î ¹ß»ýÇϸç, »ó´ç¼ö¿¡¼­´Â °¨¿° °æ·Î¸¦ ¸ð¸£´Â °æ¿ìµµ ÀÖ´Ù. 2. Áõ»ó : ´ëºÎºÐÀÇ ³ú ³ó¾çÀº 20¼¼ ÀÌÀü¿¡ ¹ß»ýµÇ´Âµ¥ ±× ÀÌÀ¯´Â ÀÌ ¿¬·É ±º¿¡¼­ ÁßÀÌ¿°À̳ª Ãà³óÁõÀÇ ºóµµ°¡ ³ôÀ¸¸ç, ¼±Ãµ¼º ½ÉÀ庴¿¡ ±âÀÎµÈ ³ú ³ó¾çÀÌ ÁÖ·Î ¼Ò¾Æ±â¿¡ ¹ß»ýµÇ±â ¶§¹®ÀÌ´Ù. 3´ë 2¿¡¼­ 2´ë 1ÀÇ ºñÀ²·Î ³²ÀÚ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÁßÀÌ¿°¿¡¼­ ¹ß»ýµÈ °æ¿ì¿¡´Â ÁÖ·Î ÃøµÎ¿±¿¡ ¹ß»ýµÇ¸ç °¡²û ÃøµÎ¿±À̳ª ÅÍŰ¾È¿¡µµ »ý±ä´Ù. Ç÷¾×À» ÅëÇÏ¿© ÀüÀÌµÈ °æ¿ì°¡ ÃÖ±Ù Áõ°¡µÇ°í Àִµ¥ ´ëºÎºÐ ´Ù¹ß¼ºÀ̰ųª ±íÀº °÷¿¡ À§Ä¡Çϰí óÀ½ Áø´Ü ½Ã °æ°è°¡ È®½ÇÄ¡ ¾ÊÀº Ư¡ÀÌ ÀÖ¾î ¿¹Èİ¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. ÁÖ Áõ»óÀ̳ª ½Å°æÇÐÀû ÀÌ»ó Á¤µµ´Â ³ó¾çÀÇ ºÎÀ§, Å©±â, º´¼ÒÀÇ ¼ö, ¿øÀαÕÀÇ µ¶¼º, ÁÖº¯ ³ú ºÎÁ¾ÀÇ Á¤µµ, °¨¿°¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀ µî¿¡ µû¶ó ´Ù¸£¸ç ÀϹÝÀûÀ¸·Î ³ú Á¶Á÷ÀÇ ÆÄ±«¿Í Á¾±« È¿°ú¿¡ µû¶ó µÎ°³°­ ³»¾ÐÀÇ »ó½Â°ú ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Áõ»ó ¹ßÇö°ú Áø´Ü±îÁöÀÇ ±â°£Àº 75%¿¡¼­ 2ÁÖ À̳»ÀÌ¸ç °¡Àå ÈçÇÑ Áõ»óÀº Á¡Â÷ ½ÉÇØÁö´Â µÎÅëÀ¸·Î 70-95%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª¸ç ÁÖ·Î ¿À½É°ú ±¸Å並 µ¿¹ÝÇÑ´Ù. ¹ßÀÛÀÌ 30-50%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª°í ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­ ¹Ì¿­ÀÌ ³ªÅ¸³ªÁö¸¸ 39µµ ÀÌ»óÀÇ °í¿­Àº µå¹°´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â Çö±âÁõÀ̳ª ÇöÈÆÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÔ¿ø½Ã ¾à ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­´Â ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀÌ ³ªÅ¸³ª¸ç µÎ°³°­ ³»¾ÐÀÇ »ó½ÂÀ¸·Î 23-50%¿¡¼­ À¯µÎ ºÎÁ¾À» º¼ ¼ö ÀÖ´Ù. ÀÔ¿ø ½Ã¿¡ ¹Ý¼ö À̻󿡼­ ÀÇ½Ä Àå¾Ö°¡ ÀÖÀ¸¸ç °æÇÑ ÀǽÄÀÇ Àå¾Ö·ÎºÎÅÍ È¥¼ö »óűîÁö ¿©·¯ Á¤µµ·Î ³ªÅ¸³­´Ù. óÀ½ ÀǽÄÀÇ Á¤µµ°¡ ȯÀÚÀÇ ¿¹ÈÄ¿¡¼­ °¡Àå Áß¿äÇÏ´Ù. ³ú ÇÇÁúÀ̳ª ³ú ÇÇÁú ÇϺÎÀÇ Æ¯Á¤ÇÑ ºÎÀ§ÀÇ ¼Õ»óÀ¸·Î ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ¹Ý½Å ¸¶ºñ, ¾ð¾îÀå¾Ö, ½Ã¾ß °á¼Õ µîÀ» ÈçÈ÷ º¼ ¼ö ÀÖ´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â ¼öÆò¼º ¾È±¸ ÁøÅÁ
  • brain center
    ´ë³ú ÁßÃß
  • brain concussion
    ³úÁøÅÁ
    µÎºÎ¿¡ °­ÇÑ ¿Ü·ÂÀÌ ÀÛ¿ëÇÑ Á÷ÈÄ¿¡ ÀϾ´Â Áõ¼¼. µÎºÎ¿¡ ¿Ü·ÂÀÌ ÀÛ¿ëÇÔ°ú µ¿½Ã¿¡ Àϰú¼ºÀÇ ÀÇ½Ä ¼Ò½ÇÀ» ÀÏÀ¸Å°Áö¸¸ ³ú ½ÇÁúÀÇ ÆÄ±«´Â ÀϾÁö ¾ÊÀº »óÅÂÀÌ´Ù. ´Ü½Ã°£
  • brain damage
    ³ú ¼Õ»ó
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
  • brain injury
    ³ú ¼Õ»ó
  • brain peptide
    ³ú ÆéƼµå
  • brain sand
    ³ú»ç
    ³úÀÇ ÀÏÁ¤ ºÎºÐ¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÛÀº ¸ð·¡ ¸ð¾çÀÇ ´Ü´ÜÇÑ ÀÔÀÚ. ¼®È¸°¡ Ä§ÂøµÇ¾î »ý±ä °ÍÀÌ´Ù. ³ú»ç°¡ ¸ð¿© ÀÖ´Â ºÎÀ§´Â º¸Åë ¼Û°ú¼±°ú ±× ºÎ±ÙÀε¥ ÀþÀº »ç¶÷¿¡°Ô´Â ¾ø°í ³ëÀο¡°Ô ¸¹´Ù. ±×·¯¹Ç·Î À̰ÍÀº ÅðÈ­ Çö»óÀ¸·Î »ý°¢µÇ¸ç, ¶Ç ³ú»çÀÇ ³»ºÎ¿¡´Â ÁÙ¹«´Ì°¡ ÀÖ´Â °ÍÀ¸·Î º¸¾Æ óÀ½¿¡´Â ÀÛÀº °ÍÀÌ Â÷Â÷ Ä¿Áø °ÍÀ̶ó »ý°¢µÈ´Ù. µ¿½É¼ºÀÇ Çϳª ÇϳªÀÇ ³ú»ç ÇüÅ´ ±¸»óÀÌ ¸¹°í, Ç¥¸éÀº »Í³ª¹« ¿­¸Å ¸ð¾çÀ¸·Î ¿ïÅüºÒÅüÇÏ´Ù. ³ú»ç°¡ ÁÖ¼ººÐÀ¸·Î µÇ¾î °áÇÕÁ¶Á÷À̳ª Ç÷°ü°ú ¹¶ÃÄÁø µ¢¾î¸®°¡ µå¹°°Ô ³úÀÇ ³»ºÎ ¶Ç´Â ±× °¡±îÀÌ¿¡ »ý±â´Â °æ¿ì°¡ ÀÖ´Ù. ±×°ÍÀ» ³ú»çÁ¾À̶ó Çϴµ¥, À̰Ϳ¡ ÀÇÇÏ¿© ³ú Á¶Á÷ÀÌ ¾Ð¹Ú ¶Ç´Â ÆÄ±«µÇ¸é ±×¿¡ µû¸£´Â Áõ¼¼°¡ ³ªÅ¸³­´Ù. ¸Å¿ì Å« ³ú»çÁ¾ÀÌ Á¦ 4³ú½Ç¿¡ »ý°Ü ¼ö¾×ÀÇ È帧À» ¹æÇØÇÏ´Â ¿¹µµ ÀÖ´Ù.
  • brain stem
    ³ú°£
    ´ë³ú ¹Ý±¸¸¦ ô¼ö¿Í ¿¬°áÇÏ´Â ½Å°æÁ¶Á÷À¸·Î¼­ ¿¬¼ö, ³ú±³ ¹× Áß³ú·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
diffuse gallbladder wall thickening <radiology> Criterion: gall bladder wall greater than 3 mm may appear thicker due to surrounding ascites, cholecystitis (acute or chronic), non-fasting state, chronic hypoalbuminaemia, hepatitis, congestive heart failure, fat in gall bladder fossa Cf: focal thickening
(12 Dec 1998)
diffuse ganglion A cystic swelling due to inflammatory effusion into one or several adjacent tendon sheaths.
(05 Mar 2000)
diffuse glomerulonephritis Glomerulonephritis affecting most of the renal glomeruli; it may lead to azotemia.
(05 Mar 2000)
diffuse goiter Goiter in which the morbid process involves the whole gland, as opposed to nodular goiter or thyroid adenoma.
(05 Mar 2000)
diffuse idiopathic skeletal hyperostosis A form of degenerative arthritis characteristically associated with flowing calcification along the sides of the vertebrae of the spine and commonly with inflammation (tendinitis) and calcification of the tendons at their attachments points to bone. Because areas of the spine and tendons can become inflamed, antiinflammatory medications (NSAIDs), such ibuprofen, can be helpful in both relieving pain and inflammation. Also called Forestier's disease.
(12 Dec 1998)
diffuse infantile familial sclerosis <radiology> Dysmyelinating disease, autosomal recessive, usually presents by 1 yr, specific enzyme deficiency identified, rapid spontaneous nystagmus, poikilothermia
Synonym: Krabbe leukodystrophy
(12 Dec 1998)
diffuse interstitial fibrosis Progressive fibrous changes and scarring within the lung tissue, eventually interfering with normal gas exchange.
(27 Sep 1997)
diffuse interstitial pulmonary fibrosis This represents a group of pulmonary disorders (lower respiratory tract) that leads to a functional loss in the alveolar air sacs and a compromise in the diffusion of oxygen from air to blood. There is widespread inflammation and scar tissue (fibrosis) formation within the lung. The causes are varied and include: inorganic and organic dusts, gases, fumes, vapors, infections, radiation, medications, coal dust, silicosis and byssinosis. When the cause is not identifiable it is referred to as idiopathic diffuse interstitial pulmonary fibrosis
(27 Sep 1997)
diffuse leishmaniasis Leishmaniasis caused by several New and Old World species and strains of Leishmania (L. Mexicana amazonensis, L. M. Pifanoi, possibly L. M. Garnhami and L. M. Venezuelensis; in Ethiopia, L. Aethiopica, and unidentified leishmanial agents in Namibia and Tanzania). The condition is associated with a suppressed cell-mediated immune response, so that the non-ulcerating, non-necrotizing cutaneous lesions can spread widely over the body; great numbers of parasite-filled macrophages are found in the dermal lesions. Healing does not appear to occur unless an acquired cellular hypersensitivity can develop.
Synonym: anergic leishmaniasis, diffuse leishmaniasis, disseminated cutaneous leishmaniasis, leishmaniasis tegumentaria diffusa, pseudolepromatous leishmaniasis.
(05 Mar 2000)
diffuse mastocytosis Infiltration of many organ systems by mast cells with varied clinical manifestations that can include fever, weight loss, flushing, bronchospasm, rhinorrhoea, palpitations, dyspnea, diarrhoea, gastrointestinal bleeding, and hypotension.
Synonym: systemic mastocytosis.
(05 Mar 2000)
diffuse mesangial proliferation <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
diffuse nontoxic goitre A common cause of hyperthyroidism thought to be caused by an underlying autoimmune mechanism.
(27 Sep 1997)
diffuse obstructive emphysema The major component of chronic obstructive lung disease.
(05 Mar 2000)
diffuse oesophageal spasm A disorder characterised by episodic contractions of the oesophagus. The oesophageal spasms fail to effectively propel food to the stomach.
Symptoms may be confused with angina. Common symptoms include chest pains, epigastric pain, heartburn, pain on swallowing and difficulty swallowing.
Treatment includes the use of sublingual nitroglycerin and calcium channel blockers.
(27 Sep 1997)
diffuse osteosclerosis <radiology> Mnemonic: 3M PROFS, renal osteodystrophy, metastasis, mastocytosis, myelofibrosis, sickle cell disease, osteopetrosis (Albers-Schoenberg disease), pyknodysostosis, fluorosis
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain truster
    Á¤Ã¥°í¹®
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • brain work
    Á¤½Å³ëµ¿ÀÚ
  • electronic brain
    ÀüÀÚ µÎ³ú(ÀüÀÚ °è»ê±â µûÀ§)
  • mechanical brain
    Àΰø µÎ³ú 
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • right-brain
    ¿ì³ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á